Huadong, Medicine Huadong Medicine Announces Positive Preliminary Results from a Phase - study of HDM2005, a ROR1-Targeting ADC 05.09.2025 - 15:26:30 HuaDong Medicine Denmark Finland Germany Netherlands Sweden United Kingdom New York China View original content:https://www.prnewswire.co.uk/news-releases/huadong-medicine-announces-positive-preliminary-results-from-a-phase--study-of-hdm2005-a-ror1-targeting-adc-302547725.html
